SIC
RCEL icon

SJS Investment Consulting’s Avita Medical RCEL Stock Holding History

SJS Investment Consulting’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141 Buy
34
+32
+1,600% +$138 ﹤0.01% 2541
2026
Q1 		$8 Buy
+2
New +$8 ﹤0.01% 2433

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SJS Investment Consulting's RCEL Position: Q2 2026 in Review

SJS Investment Consulting increased its Avita Medical (RCEL) stake by 1,600% in Q2 2026, buying an estimated $138 and bringing the position to 34 shares worth $141. The position accounts for ﹤0.01% of the portfolio, ranked #2541.

SJS Investment Consulting first reported a position in RCEL in Q1 2026 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • SJS Investment Consulting held 34 shares of Avita Medical worth $141 as of Q2 2026.
  • SJS Investment Consulting bought 32 Avita Medical shares in Q2 2026, an estimated $138.
  • Avita Medical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2541 holding.
  • SJS Investment Consulting first reported a position in Avita Medical in Q1 2026 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.